Prevention/Screening

The Future of Pancreatic Cancer Treatments

The Future of Pancreatic Cancer Treatments

Posted by  | Issues & Perspectives, pancreatic cancer, Prevention/Screening, Research, treatment

Just eight percent of people with pancreatic cancer live for five years after their diagnosis. Why is this cancer so deadly and where are advances in treatment headed? Elizabeth Jaffee, M.D., deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, describes explains in a 2018 interview on WYPR. http://www.wypr.org/post/why-pancreatic-cancer-so-deadly

Jaffee looks to the future of checkpoint immunotherapy for cancer treatment

Jaffee looks to the future of checkpoint immunotherapy for cancer treatment

Posted by  | Issues & Perspectives, precision medicine, Prevention/Screening, treatment

Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research(...)

Washington Post Cancer Summit: A Silent Epidemic: The rise of HPV-related cancers

Posted by  | Issues & Perspectives, Prevention/Screening, Research

Akila Viswanathan, M.D., executive vice chair of Johns Hopkins Radiation Oncology and Molecular Radiation Sciences, was part of a panel discussion on the rise of HPV-related cancers. The panel was just one section of the Washington Post Cancer Summit. Viswanathan was joined by other experts in taking look at rising HPV-related cancer rates in the(...)

A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet

A Look Inside the Kimmel Cancer Center’s Cancer Medicine Cabinet

Posted by  | Issues & Perspectives, Patient Stories, Prevention/Screening, Research, treatment

Read the latest issue of Promise & Progress featuring research advances in cancer drug discovery and development, promising new cancer drugs, patient stories and more. From scientific meetings to our own dinner tables, conversations about better treatments for cancer are among the most frequently discussed health care topics. Everyone wants them—the doctors and scientists who(...)

Early-Stage Prostate Cancer: To Treat or Not to Treat

Early-Stage Prostate Cancer: To Treat or Not to Treat

Posted by  | Prevention/Screening

Prostate cancer is a leading health problem for men. As strategies for prostate cancer screening and active surveillance are refined, men may benefit from early detection and cure of life-threatening prostate cancer but avoid overtreatment of the non-life-threatening variety. Read Kimmel Cancer Center director William Nelson’s editorial in Cancer Today, a publication of the American(...)